Target audience:
Presidents, CEOs, CSOs and other Management Professionals
Professors, Post docs, and Graduate students from Academia
R & D Scientists from Biotech & Pharma Industry
Clinical Fellows, Residents & Nurses from Health Care Industry
Business Development & Marketing Professionals
Investment, Technology Acquisition Portfolio Managers.
Keytopics:
鈥iology of Diabetes, Obesity & Adipogenesis
鈥etection/Diagnosis using Biomarkers & Imaging
鈥nsulin Resistance & Sugar Signaling Mechanisms
鈥ovel Insulin Delivery Method
鈥enomic Studies of Complex Metabolic Diseases
鈥ultiplex & High throughput Technology Platforms
鈥ranslational Medicine of Body Weight Regulation
鈥ardiovascular outcome in Diabetes & Obesity
鈥linical, Etiological and Epidemiological Studies
鈥linical Trials with Novel Anti-diabetic & Anti-obesity Drug Targets
Presidents, CEOs, CSOs and other Management Professionals
Professors, Post docs, and Graduate students from Academia
R & D Scientists from Biotech & Pharma Industry
Clinical Fellows, Residents & Nurses from Health Care Industry
Business Development & Marketing Professionals
Investment, Technology Acquisition Portfolio Managers.
Keytopics:
鈥iology of Diabetes, Obesity & Adipogenesis
鈥etection/Diagnosis using Biomarkers & Imaging
鈥nsulin Resistance & Sugar Signaling Mechanisms
鈥ovel Insulin Delivery Method
鈥enomic Studies of Complex Metabolic Diseases
鈥ultiplex & High throughput Technology Platforms
鈥ranslational Medicine of Body Weight Regulation
鈥ardiovascular outcome in Diabetes & Obesity
鈥linical, Etiological and Epidemiological Studies
鈥linical Trials with Novel Anti-diabetic & Anti-obesity Drug Targets